Jazz Pharmaceuticals plc
JAZZ
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic andā¦ read more
Healthcare
Biotechnology
19 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$252.86
Price-2.14%
-$5.52
1Y
Price
Market Cap
$15.884b
Large
Price/Earnings 3y Avg5y Avg
19.7x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+50.9%
EBITDA Margin+27.4%
Net Profit Margin+36.4%
Free Cash Flow Margin+50.9%
EBITDA Margin+27.4%
Net Profit Margin+36.4%
Free Cash Flow MarginRevenue
$4.439b
+4.0%
1y CAGR+5.0%
3y CAGR+5.0%
5y CAGREarnings
$29.493m
+108.3%
1y CAGR-6.8%
3y CAGR+66.2%
5y CAGREPS
$0.11
+101.9%
1y CAGR-7.9%
3y CAGR+61.6%
5y CAGRBook Value
$4.532b
$11.860b
Assets$7.327b
Liabilities$5.417b
DebtDebt to Assets
45.7%
10x
Debt to EBITDAFree Cash Flow
$1.246b
+8.7%
1y CAGR+6.6%
3y CAGR+14.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company